Santosh J. Vetticaden

2013 - Mast Therapeutics

In 2013, Santosh J. Vetticaden earned a total compensation of $522.3K as Former Chief Medical Officer and Senior Vice President at Mast Therapeutics, a 17% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$104,891
Option Awards$50,313
Salary$350,000
Other$17,094
Total$522,298

Vetticaden received $350K in salary, accounting for 67% of the total pay in 2013.

Vetticaden also received $104.9K in non-equity incentive plan, $50.3K in option awards and $17.1K in other compensation.

Rankings

In 2013, Santosh J. Vetticaden's compensation ranked 9,217th out of 12,286 executives tracked by ExecPay. In other words, Vetticaden earned more than 25.0% of executives.

ClassificationRankingPercentile
All
9,217
out of 12,286
25th
Division
Manufacturing
3,370
out of 4,612
27th
Major group
Chemicals And Allied Products
1,072
out of 1,466
27th
Industry group
Drugs
824
out of 1,160
29th
Industry
Pharmaceutical Preparations
647
out of 890
27th
Source: SEC filing on April 29, 2015.

Vetticaden's colleagues

We found two more compensation records of executives who worked with Santosh J. Vetticaden at Mast Therapeutics in 2013.

2013

Brian Culley

Mast Therapeutics

Chief Executive Officer

2013

Patrick Keran

Mast Therapeutics

Chief Operating Officer

News

You may also like